Coronary bypass graft patency cannot be determined by multidetector spiral computed tomography

Kristian Bartnes1, Trude Sildnes, Amjid Iqbal

  • 1Department of Cardiothoracic and Vascular Surgery, University Hospital North Norway, Tromsø, Norway. kristian.bartnes@unn.no

Insights

Sixteen-slice multidetector computed tomography (MDCT) cannot replace selective angiography for coronary bypass graft patency assessment. MDCT had a 24% non-evaluable rate and a 6% error rate in this study.

Area of Science:

  • Cardiovascular Imaging
  • Radiology

Background:

  • Selective catheterization angiography is the gold standard for coronary bypass graft patency but poses risks.
  • Coronary artery bypass grafting (CABG) requires reliable graft patency assessment.

Purpose of the Study:

  • To evaluate if 16-slice multidetector computed tomography (MDCT) can serve as a substitute for selective angiography in assessing coronary bypass graft patency.

Main Methods:

  • 45 patients underwent both MDCT and selective angiography 2-3 years post-CABG.
  • A total of 156 grafts (single and sequential) were analyzed and classified as patent, stenotic, or occluded.

Main Results:

  • MDCT showed a high likelihood ratio for detecting occlusion.
  • However, 24% of distal anastomoses were unevaluable by MDCT due to artifacts and small vessel size.
  • MDCT misclassified 6% of evaluable grafts.

Conclusions:

  • 16-slice MDCT is currently not a suitable replacement for selective angiography in coronary bypass graft assessment.
  • The high non-evaluable rate and error rate preclude its use as a definitive diagnostic tool.
Abstract